semaglutide and low libido Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, a biopsychosocial model for why we don't 'see' it Are Sexual Side Effects Emerging

Mood improvements may result from better glycaemic control, weight loss, improved physical health, and enhanced self-esteem rather than direct effects on serotonin or other mood-regulating neurotransmitters

K., Baez, S., Johansson, A

Weight loss plateaus are common, even when using GLP-1 medications

GLP-1 receptor agonists have driven significant cost increases across Canadian group benefits portfolios, with some insurers flagging the drug class as a top contributor to rising claims

309,310,311,312 CD38 is under the transcriptional control of RSVinduced IFNs

The study compared patients who used GLP-1 agonists versus those who used bupropion-naltrexone, a drug used to treat chronic obesity